A detailed history of Valeo Financial Advisors, LLC transactions in Sanofi stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 14,472 shares of SNY stock, worth $698,708. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,472
Previous 13,979 3.53%
Holding current value
$698,708
Previous $678,000 23.01%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$48.54 - $58.53 $23,930 - $28,855
493 Added 3.53%
14,472 $834,000
Q2 2024

Jul 10, 2024

BUY
$45.39 - $50.36 $5,401 - $5,992
119 Added 0.86%
13,979 $678,000
Q1 2024

Apr 25, 2024

BUY
$45.75 - $52.48 $10,065 - $11,545
220 Added 1.61%
13,860 $673,000
Q1 2024

Apr 19, 2024

BUY
$45.75 - $52.48 $67,527 - $77,460
1,476 Added 12.13%
13,640 $662,000
Q4 2023

Jan 29, 2024

SELL
$43.13 - $54.79 $73,364 - $93,197
-1,701 Reduced 12.27%
12,164 $604,000
Q3 2023

Oct 19, 2023

SELL
$50.95 - $55.2 $3,311 - $3,588
-65 Reduced 0.47%
13,865 $743,000
Q2 2023

Jul 14, 2023

BUY
$50.45 - $57.18 $408,544 - $463,043
8,098 Added 138.85%
13,930 $750,000
Q1 2023

Apr 17, 2023

BUY
$45.86 - $54.45 $21,462 - $25,482
468 Added 8.72%
5,832 $317,000
Q4 2022

Feb 09, 2023

BUY
$38.86 - $48.55 $208,445 - $260,422
5,364 New
5,364 $259,000
Q2 2022

Aug 03, 2022

SELL
$48.99 - $57.46 $440 - $517
-9 Reduced 0.21%
4,236 $212,000
Q1 2022

Apr 28, 2022

SELL
$48.48 - $53.65 $63,411 - $70,174
-1,308 Reduced 23.55%
4,245 $218,000
Q4 2021

Jan 07, 2022

SELL
$47.07 - $52.35 $1,270 - $1,413
-27 Reduced 0.48%
5,553 $278,000
Q3 2021

Nov 02, 2021

BUY
$47.89 - $53.12 $29,452 - $32,668
615 Added 12.39%
5,580 $269,000
Q2 2021

Jul 22, 2021

SELL
$49.36 - $54.25 $16,190 - $17,794
-328 Reduced 6.2%
4,965 $261,000
Q1 2021

Apr 12, 2021

SELL
$45.46 - $50.51 $7,091 - $7,879
-156 Reduced 2.86%
5,293 $262,000
Q4 2020

Feb 11, 2021

BUY
$45.3 - $51.62 $11,959 - $13,627
264 Added 5.09%
5,449 $265,000
Q3 2020

Oct 28, 2020

SELL
$49.47 - $53.77 $47,590 - $51,726
-962 Reduced 15.65%
5,185 $260,000
Q2 2020

Jul 20, 2020

BUY
$42.91 - $52.5 $55,182 - $67,515
1,286 Added 26.46%
6,147 $314,000
Q4 2019

Jan 24, 2020

SELL
$44.25 - $50.86 $15,576 - $17,902
-352 Reduced 6.75%
4,861 $244,000
Q3 2019

Oct 15, 2019

SELL
$40.34 - $46.64 $12,828 - $14,831
-318 Reduced 5.75%
5,213 $242,000
Q2 2019

Jul 10, 2019

SELL
$40.43 - $44.3 $10,390 - $11,385
-257 Reduced 4.44%
5,531 $239,000
Q1 2019

Apr 12, 2019

SELL
$40.83 - $45.43 $28,581 - $31,801
-700 Reduced 10.79%
5,788 $256,000
Q4 2018

Jan 30, 2019

SELL
$41.48 - $45.59 $34,262 - $37,657
-826 Reduced 11.29%
6,488 $282,000
Q3 2018

Nov 01, 2018

SELL
$40.0 - $44.84 $61,760 - $69,232
-1,544 Reduced 17.43%
7,314 $327,000
Q2 2018

Aug 14, 2018

SELL
$37.63 - $41.22 $15,879 - $17,394
-422 Reduced 4.55%
8,858 $368,000
Q1 2018

Apr 12, 2018

SELL
$38.98 - $45.76 $202,189 - $237,357
-5,187 Reduced 35.85%
9,280 $372,000
Q4 2017

Feb 09, 2018

BUY
$42.86 - $50.61 $214,042 - $252,746
4,994 Added 52.72%
14,467 $622,000
Q3 2017

Nov 14, 2017

BUY
$47.04 - $50.34 $445,609 - $476,870
9,473
9,473 $472,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.